Vanguard Group Inc En V Veno Medical Corp Call Options Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NVNO
# of Institutions
37Shares Held
4.05MCall Options Held
274KPut Options Held
17.8K-
Kingdon Capital Management, L.L.C. New York, NY654KShares$3.32 Million0.43% of portfolio
-
Perceptive Advisors LLC New York, NY623KShares$3.16 Million0.07% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT496KShares$2.51 Million0.17% of portfolio
-
Act Capital Management, LLC Wayne, PA401KShares$2.03 Million3.48% of portfolio
-
Ubs Oconnor LLC Chicago, IL226KShares$1.15 Million0.08% of portfolio
About enVVeno Medical Corp
- Ticker NVNO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 9,469,850
- Market Cap $48M
- Description
- enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...